Related Experiment Video
Updated: May 22, 2026

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle
Published on: June 7, 2024
A roundabout way to cancer
Mimmi S Ballard1, Lindsay Hinck
1Department of Molecular, Cell and Developmental Biology, University of California, Santa Cruz, CA, USA.
Abstract:
The Slit family of secreted proteins and their transmembrane receptor, Robo, were originally identified in the nervous system where they function as axon guidance cues and branching factors during development. Since their discovery, a great number of additional roles have been attributed to Slit/Robo signaling, including regulating the critical processes of cell proliferation and cell motility in a variety of cell and tissue types. These processes are often deregulated during cancer progression, allowing tumor cells to bypass safeguarding mechanisms in the cell and the environment in order to grow and escape to new tissues. In the past decade, it has been shown that the expression of Slit and Robo is altered in a wide variety of cancer types, identifying them as potential therapeutic targets. Further, studies have demonstrated dual roles for Slits and Robos in cancer, acting as both oncogenes and tumor suppressors. This bifunctionality is also observed in their roles as axon guidance cues in the developing nervous system, where they both attract and repel neuronal migration. The fact that this signaling axis can have opposite functions depending on the cellular circumstance make its actions challenging to define. Here, we summarize our current understanding of the dual roles that Slit/Robo signaling play in development, epithelial tumor progression, and tumor angiogenesis.
Insights
Slit/Robo signaling regulates cell growth and movement. This pathway has dual roles in cancer, acting as both oncogenes and tumor suppressors, impacting tumor progression and angiogenesis.
Area of Science:
- Molecular Biology
- Developmental Biology
- Cancer Research
Background:
- Slit/Robo signaling is crucial for nervous system development, controlling axon guidance and branching.
- This signaling pathway also regulates cell proliferation and motility in various tissues.
- Altered Slit/Robo expression is observed in many cancers, suggesting therapeutic potential.
Purpose of the Study:
- To summarize the dual roles of Slit/Robo signaling in development and cancer.
- To explore the involvement of Slit/Robo in epithelial tumor progression and angiogenesis.
Main Methods:
- Literature review and synthesis of existing research on Slit/Robo signaling.
- Analysis of studies investigating Slit/Robo expression and function in cancer models.
Main Results:
- Slit/Robo signaling exhibits bifunctional roles, acting as both oncogenes and tumor suppressors in cancer.
- This signaling axis influences cell proliferation, motility, epithelial tumor progression, and angiogenesis.
- The context-dependent functions of Slit/Robo signaling present challenges in defining its precise role.
Conclusions:
- Slit/Robo signaling is a complex pathway with significant implications in both normal development and cancer.
- Understanding the dual roles of Slit/Robo is critical for developing targeted cancer therapies.
- Further research is needed to elucidate the precise mechanisms underlying Slit/Robo's context-dependent functions in tumorigenesis.
Related Concept Videos
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Cancer
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

